Clinical trials
End Stage Kidney Disease clinical trials
Below are recruiting end stage kidney disease clinical trials, each written for real people, not researchers. We’re tracking 141 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04160507Recruiting
Biobank study collecting samples about kidney health in Black adults
This study builds a research “bank” (biorepository) of blood and other samples from Black adults with different stages of kidney health, including people with kidney disease and people without known kidney disease. It may help researchers better understand kidney risk and causes over time.
Durham, North CarolinaAges 18 years+ - NCT03573089Recruiting
Testing higher vs standard phosphate targets in dialysis patients
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
Camperdown, New South WalesAges 18 years+ - NCT03032835Recruiting
Research study for calciphylaxis skin lesions
This study collects and stores information from people with calciphylaxis, a serious condition that causes painful skin lesions. It may help researchers learn more about the disease and improve future care.
Boston, MassachusettsAges 18 years+ - NCT02699736Enrolling by invitation
HIV and hepatitis C study in European adults
This study follows people living with HIV who also have hepatitis C antibodies, to better understand how HIV and hepatitis C affect health over time. You may be able to join if you meet the age and enrollment requirements, even if your hepatitis C virus level is currently undetectable.
Buenos AiresAges 16 years+ - NCT03716401Recruiting
Imaging tests to predict kidney disease in type 2 diabetes
This study uses special kidney imaging to look for patterns that can predict how diabetic kidney disease may progress. It may help researchers find better ways to identify people at higher risk using noninvasive (and possibly biopsy-related) tests.
TurkuAges 18–80 - NCT05071131Recruiting
Inulin supplement to improve gut health in kidney disease
This trial studies whether taking inulin—a dietary fiber—can improve gut bacteria and the gut barrier in people with end-stage kidney disease on hemodialysis. It may help reduce gut-related problems that can affect overall health in kidney disease.
BerlinAges 18–75 - NCT06750575Recruiting
Study of furosemide on toxin removal in chronic kidney disease
This study tests whether the water pill furosemide can help remove certain toxins from the blood in people with chronic kidney disease (CKD stages 3-5) who are starting this medicine as part of their regular care.
Utrecht, UtrechtAges 18 years+ - NCT07271186RecruitingPhase 2
Study of an experimental drug for kidney disease from type 2 diabetes
This study tests an investigational drug called ALN-ANG3 to see if it can help people with diabetic kidney disease. The drug may reduce kidney damage and slow down the loss of kidney function. If you join, you will get the study drug or a placebo (a dummy shot) and be followed by a study doctor.
Huntsville, AlabamaAges 18–80 - NCT07792317Recruiting
Cold storage treatment for donated kidneys before transplant
This study tests a special cold storage solution and machine to keep donated kidneys healthy before they are transplanted. It may help the kidneys work better after surgery.
RotterdamAges 18 years+ - NCT06483074RecruitingPhase 2
Empagliflozin to preserve kidney function in new peritoneal dialysis patients
This trial tests whether empagliflozin, a medication originally for diabetes, can help protect the remaining kidney function in people who have just started peritoneal dialysis. If you started dialysis within the last 3 months and still make some urine, this study may be a good fit.
Hong KongAges 18–75 - NCT03321656RecruitingPhase 2/Phase 3
Envarsus XR after kidney transplant to reduce hidden rejection
This study looks at whether Envarsus XR helps prevent “subclinical” (not obviously noticeable) kidney transplant rejection by changing blood immune test results. You may be able to join if you recently received a kidney transplant and can take the study medicine as required.
Lexington, KentuckyAges 18–75 - NCT06372743Recruiting
Nurse-led care for kidney disease with other health issues
This study tests a nurse-led care model with doctor support for people with chronic kidney disease who also have other health problems like high blood pressure or diabetes. Its goal is to help you better manage your health and avoid complications.
SingaporeAges 21 years+ - NCT07763418RecruitingPhase 1
Kidney function study of golcadomide
This study tests how a new drug, golcadomide, works in people with severe kidney problems compared to those with normal kidneys. It helps see if the drug needs different dosing for patients with kidney issues.
Chandler, ArizonaAges 18–84 - NCT05457283RecruitingPhase 3
Finerenone safety study for children with kidney disease
This trial studies how safely finerenone works over 18 months in children and young adults with chronic kidney disease who also take an ACE inhibitor or ARB. It aims to better understand long-term side effects when used together with standard kidney blood-pressure medicines.
Phoenix, ArizonaAges 1–18 - NCT07151742Enrolling by invitation
Exercise during dialysis for muscle health
This study tests whether exercise during hemodialysis can improve muscle oxygen levels and how well dialysis works. It is for people who have been on dialysis for at least a year and have muscle loss (sarcopenia).
Istanbul, KadikoyAges 18–65 - NCT05738525Recruiting
Compare two types of home dialysis for kidney outcomes and quality of life
This study compares two forms of home peritoneal dialysis—how well they work for kidney health and how they affect daily life. You may be considered if you have end-stage kidney disease and meet specific test and safety requirements.
Beijing, Beijing MunicipalityAges 18–75 - NCT07866872Enrolling by invitation
Blood volume monitoring for dialysis patients with fluid overload
This study tests whether using a device that monitors blood volume during dialysis can help manage fluid overload and reduce hospital readmissions for patients with kidney failure.
Boston, MassachusettsAges 18 years+ - NCT04360694Recruiting
Testing a step-up hemodialysis schedule for new dialysis patients
This trial studies whether starting hemodialysis in a gradual “step-up” way is safe and works well for adults who are newly starting maintenance dialysis for advanced kidney failure. If you qualify, you may be assigned to a specific dialysis start plan and be closely monitored.
BariAges 18 years+ - NCT07720401Recruiting
Exercise during dialysis for posture problems
This study tests if doing gentle exercise during dialysis can help improve posture problems like a rounded upper back or forward head tilt. It is a small, early-stage study to see if the exercises are safe and might help.
IsfahanAges 18–80 - NCT07561138Recruiting
Nutrition and Exercise Training Before Liver Transplant
This study tests whether eating better and doing gentle exercise before your liver transplant can help you stay healthier and recover better after surgery. You'll work with a nutrition expert and exercise specialist to prepare your body for transplant.
Athens, AtticaAges 18–70 - NCT06597201RecruitingPhase 4
Testing Amino Acid Dialysis Solution for Malnutrition on Peritoneal Dialysis
This trial tests a special peritoneal dialysis solution with amino acids (protein building blocks) to improve nutrition in people on CAPD who are malnourished. It might help boost your protein levels and overall health.
Hefei, AnhuiAges 18–75 - NCT06836206RecruitingPhase 1/Phase 2
Gum arabic and kidney function in dialysis patients
This trial tests if taking gum arabic, a natural fiber, can help preserve the remaining kidney function in adults on dialysis. If you produce at least 200 ml of urine a day, this study might help you learn about a possible way to protect your kidneys.
Abu DhabiAges 18 years+ - NCT07370441Enrolling by invitationPhase 4
Amino acid dialysis fluid for better nutrition
This trial tests a special dialysis fluid with amino acids (building blocks of protein) to see if it helps improve nutrition in people on peritoneal dialysis who have low protein levels. If you qualify, it may help boost your nutrition.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07291154Recruiting
Using an app to improve dialysis quality
This trial tests if a smartphone app (via WeChat) can help people on dialysis better manage their treatment and improve quality of care. It's for adults who have been on regular dialysis for at least 3 months.
Chongqing, Chongqing MunicipalityAges 18–75
Hear when a new End Stage Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for end stage kidney disease?
- Yes. Clin2 currently lists 141 recruiting end stage kidney disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a end stage kidney disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a end stage kidney disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.